As a prime example, DNA mismatch repair-proficient or microsatellite-stable CRC colon cancer, which represent around 85% of all diagnosed CRC diseases, are characterized by low overall immunogenicity and the decreased infiltration of CD8+ T lymphocytes [10,11,12]. This evidence concerns the gene CD8A and malignant colon neoplasm.